Robert W. Carlson
Eastern Cooperative Oncology Group
Boston
USA
Name/email consistency: high
- A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer. Carlson, R.W., O'Neill, A., Vidaurre, T., Gomez, H.L., Badve, S.S., Sledge, G.W. Breast Cancer Res. Treat. (2012)
- Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women. Carlson, R.W., Theriault, R., Schurman, C.M., Rivera, E., Chung, C.T., Phan, S.C., Arun, B., Dice, K., Chiv, V.Y., Green, M., Valero, V. J. Clin. Oncol. (2010)
- Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendations. Carlson, R.W., Hudis, C.A., Pritchard, K.I. J. Natl. Compr. Canc. Netw (2006)
- A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): a trial of the Eastern Cooperative Oncology Group. Carlson, R.W., O'Neill, A.M., Goldstein, L.J., Sikic, B.I., Abramson, N., Stewart, J.A., Davidson, N.E., Wood, W.C. Cancer Invest. (2006)
- The history and mechanism of action of fulvestrant. Carlson, R.W. Clin. Breast Cancer (2005)
- Treatment of breast cancer in countries with limited resources. Carlson, R.W., Anderson, B.O., Chopra, R., Eniu, A.E., Jakesz, R., Love, R.R., Masetti, R., Schwartsmann, G. Breast. J (2003)